Use of piezoelectric immunosensors for detection of interferon-gamma interaction with specific antibodies in the presence of released-active forms of antibodies to interferon-gamma

Sensors (Switzerland)

Volumn 16, Issue 1, 2016, Pages

  Don, Elena ^a   Farafonova, Olga ^b   Pokhil, Suzanna ^a   Barykina, Darya ^a   Nikiforova, Marina ^a   Shulga, Darya ^a   Borshcheva, Alena ^a   Tarasov, Sergey ^a   Ermolaeva, Tatyana ^b   Epstein, Oleg ^a  

^a OOO ‘NPF ‘MATERIA MEDICA HOLDING’ ^*  (Russian Federation)

^b LIPETSK STATE TECHNICAL UNIVERSITY   (Russian Federation)

Author keywords

Interferon gamma; Piezoelectric immunosensors; Released active forms of antibodies

Indexed keywords

ANTIBIOTICS; ANTIGENS; CHEMICAL DETECTION; ELECTRODES; GLYCOPROTEINS; IMMUNOSENSORS; PIEZOELECTRICITY; SIGNAL DETECTION;

ANALYTICAL SIGNALS; ANTIGEN-ANTIBODY INTERACTION; EXPERIMENTAL CONDITIONS; INTERFERON-GAMMA; OPTIMAL ELECTRODES; PIEZOELECTRIC IMMUNOSENSOR; SPECIFIC INTERACTION; STATISTICALLY SIGNIFICANT DIFFERENCE;

ANTIBODIES;

ANTIBODY; GAMMA INTERFERON; RECOMBINANT PROTEIN;

ANIMAL; CHEMISTRY; ELECTROCHEMICAL ANALYSIS; ELECTRODE; GENETIC PROCEDURES; HUMAN; IMMUNOASSAY; METABOLISM; PROCEDURES; RABBITS AND HARES; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES; BIOSENSING TECHNIQUES; ELECTROCHEMICAL TECHNIQUES; ELECTRODES; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; RABBITS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84955128565     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s16010096     Document Type: Article

References (45)

1. Buss, N.A.; Henderson, S.J.; McFarlane, M.; Shenton, J.M.; de Haan, L. Monoclonal antibody therapeutics: History and future. Curr. Opin. Pharmacol. 2012, 12, 615–622. [CrossRef] [PubMed]
2. Chames, P.; van Regenmortel, M.; Weiss, E.; Baty, D. Therapeutic antibodies: Successes, limitations and hopes for the future. Br. J. Pharmacol. 2009, 157, 220–233. [CrossRef] [PubMed]
3. Nielsen, O.H. New strategies for treatment of inflammatory bowel disease. Front. Med. 2014, 1. [CrossRef] [PubMed]
4. Bryant, R.; Sandborn, W.; Travis, S. Introducing vedolizumab to clinical practice: Who, when and how? J. Crohn Colitis 2015, 9, 356–366. [CrossRef] [PubMed]
5. Kaboord, B.; Perr, M. Isolation of proteins and protein complexes by immunoprecipitation. Methods Mol. Biol. 2008, 424349–364,. [PubMed]
6. Brizzard, B.L.; Chubet, R.G.; Vizard, D.L. Immunoaffinity purification of flag epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. BioTechniques 1994, 16, 730–735. [PubMed]
7. Wang, H.; Yuan, X.; Zhang, L. Latex agglutination: Diagnose the early cryptococcusneoformans test of capsular polysaccharide antigen. Pak. J. Pharm. Sci. 2015, 28, 307–311. [PubMed]
8. Wolk, M.; Kieselstein, M. Improved haemagglutination reagent for detecting antibodies to insulin in diabetic and non-diabetic young and old patients. Clin. Chim. Acta Int. J. Clin. Chem. 1984, 144, 105–113. [CrossRef]
9. Adler, M.; Schulz, S.; Spengler, M. Cytokine Quantification in Drug Development: A Comparison of Sensitive Immunoassay Platforms. Available online: http://www.bionity.com/en/whitepapers/100005/ cytokine-quantification-in-drug-development.html (accessed on 18 December 2015).
10. Kumar, R.; Sinha, R.P. Real-time immuno-PCR: An approach for detection of trace amounts of transgenic proteins. J. AOAC Int. 2014, 97, 1634–1637. [CrossRef] [PubMed]
11. Laurberg, P.; Pedersen, K.M. A sensitive radio-immunoassay for serum thyroglobulin—Including a correct screening for thyroglobulin autoantibodies. Scand. J. Clin. Lab. Investig. 1987, 47, 685–689. [CrossRef]
12. Holford, T.R.; Davis, F.; Higson, S.P. Recent trends in antibody based sensors. Biosens. Bioelectron. 2012, 34, 12–24. [CrossRef] [PubMed]
13. Lequin, R.M. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin. Chem. 2005, 51, 2415–2418. [CrossRef] [PubMed]
14. Kocoglu, M.E.; Tas, T.; Mengeloglu, F.Z.; Ozsoy, S.; Bucak, O. Evaluation of 4 methods for the serological diagnosis of epstein-barr virus infection using an immunofluorescence assay as the reference method. Turk. J. Med. Sci. 2014, 44, 914–919. [CrossRef] [PubMed]
15. Song, D.; Ha, G.; Serhan, W.; Eltahir, Y.; Yusof, M.; Hashem, F.; Elsayed, E.; Marzoug, B.; Abdelazim, A.; Muhairi, S. Development and validation of a rapid immunochromatographic assay for detection of middle east respiratory syndrome coronavirus antigen in dromedary camels. J. Clin. Microbiol. 2015, 53, 1178–1182. [CrossRef] [PubMed]
16. Rivet-Danon, D.; Guitard, J.; Grenouillet, F.; Gay, F.; Ait-Ammar, N.; Angoulvant, A.; Marinach, C.; Hennequin, C. Rapid diagnosis of cryptococcosis using an antigen detection immunochromatographic test. J. Infect. 2015, 70, 499–503. [CrossRef] [PubMed]
17. Potapova, A.A.; Chekanova, T.A.; Markelov, M.L.; Pudova, E.A.; Kirdiashkina, N.P.; Shipulina, G.A.; Dronova, V.M.; Potekaeva, N.N. The verification possibilities of immunochips under low content of antibodies to core-antigen of virus of hepatitis C. Klin. Lab. Diagn. 2013, 1, 45–48. [PubMed]
18. Fragoso, A.; Laboria, N.; Latta, D.; O’Sullivan, C.K. Electron permeable self-assembled monolayers of dithiolated aromatic scaffolds on gold for biosensor applications. Anal. Chem. 2008, 80, 2556–2563. [CrossRef] [PubMed]
19. Ermolaeva, T.K.E. Capabilities of piezoelectric immunosensors for detecting infections and for early clinical diagnostics. Adv. Immunoass. Technol. 2012, 81. [CrossRef]
20. Carlos Moina, G.Y. Fundamentals and applications of immunosensors. Adv. Immunoass. Technol. 2012. [CrossRef]
21. Longinotti, G.; Ybarra, G.; Lloret, P.; Moina, C.; Ciochinni, A.; Serantes, D.R.; Malatto, L.; Roberti, M.; Tropea, S.; Fraigi, L. Diagnosis of foot-and-mouth disease by electrochemical enzyme-linked immunoassay. In Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society, Buenos Aires, Argentina, 1–4 September 2010; Volume 2010, pp. 674–676.
22. Min, K.; Cho, M.; Han, S.Y.; Shim, Y.B.; Ku, J.; Ban, C. A simple and direct electrochemical detection of interferon-gamma using its rna and DNA aptamers. Biosens. Bioelectron. 2008, 23, 1819–1824. [CrossRef] [PubMed]
23. Rabbany, S.Y.; Donner, B.L.; Ligler, F.S. Optical immunosensors. Crit. Rev. Biomed. Eng. 1994, 22, 307–346. [PubMed]
24. Suh, Y.K.; Kim, B.C.; Kim, Y.H. Determination of viscoelastic property in polyethylene crystallization using a quartz crystal resonator. Sensors 2009, 9, 9544–9558. [CrossRef] [PubMed]
25. Avshalumov, A.; Sudakov, K.V.; Filaretov, G.F. A new information technology for system diagnosis of functional activity of human organs. Biomed. Eng. 2006, 40, 120–124. [CrossRef]
26. Epstein, O.I. Release-activity: A long way from phenomenon to new drugs. Bull. Exp. Biol. Med. 2012, 154, 54–58. [CrossRef] [PubMed]
27. Epstein, O.I. The phenomenon of release activity and the hypothesis of “spatial” homeostasis. Uspekhi Fiziol. Nauk 2013, 44, 54–76.
28. Tarasov, S.A.; Zarubaev, V.V.; Gorbunov, E.A.; Sergeeva, S.A.; Epstein, O.I. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice. Antivir. Res. 2012, 93, 219–224. [CrossRef] [PubMed]
29. Vasil’ev, A.N.; Sergeeva, S.A.; Kachanova, M.V.; Tarasov, S.A.; Elfimova, U.V.; Dugina Iu, L.; Epshtein, O.I. Use of ultralow doses of antibodies to gamma-interferon in the treatment and prophylaxis of viral infections. Antibiot. Khimioterapiia 2008, 53, 32–35.
30. Aver’ianov, A.V.; Babkin, A.P.; Bart, B.; Volchetskii, A.L.; Minina, E.S.; Kozyrev, O.A.; Kostinov, M.P.; Petrov, D.V.; Sel’kova, E.P.; Putilovskii, M.A.; et al. Ergoferon and oseltamivir in treatment of influenza: Results of multicentre randomized comparative clinical trial. Antibiot. Khimioterapiia 2012, 57, 23–30.
31. Erman, E.S.; Osidak, L.V.; Sukhovetskaya, V.F.; Drinevskii, V.P. Efficiency of interferon inductor anaferon (pediatric formulation) in prophylaxis of acute respiratory infections in sickly children. Bull. Exp. Biol. Med. 2009, 148, 270–274. [CrossRef] [PubMed]
32. Shishkina, L.N.; Sergeev, A.N.; Kabanov, A.S.; Skarnovich, M.O.; Evtin, N.K.; Mazurkova, N.A.; Sergeev, A.A.; Belopolskaya, M.V.; Kheyfets, I.A.; Dugina, J.L.; et al. Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection. Bull. Exp. Biol. Med. 2008, 146, 763–765. [CrossRef] [PubMed]
33. Shishkina, L.N.; Skarnovich, M.O.; Kabanov, A.S.; Sergeev, A.A.; Olkin, S.E.; Tarasov, S.A.; Belopolskaya, M.V.; Sergeeva, S.A.; Epstein, O.I.; Malkova, E.M.; et al. Antiviral activity of anaferon (pediatric formulation) in mice infected with pandemic influenza virus a(H1N1/09). Bull. Exp. Biol. Med. 2010, 149, 612–614. [CrossRef] [PubMed]
34. Verevshchikov, V.K.; Borzunov, V.M.; Shemiakina, E.K. Ergoferon and improvement of etiopathogenetic therapy of influenza and acute respiratore viral infection in adults. Antibiot. Khimioterapiia 2011, 56, 23–26.
35. Epstein, O.I. Ultra-Low Doses (History of One Research); Publishing Office of the Russian Academy of Medical Sciences: Moscow, Russia, 2009; pp. 1–302.
36. Nicoll, J.; Gorbunov, E.A.; Tarasov, S.A.; Epstein, O.I. Subetta treatment increases adiponectin secretion by mature human adipocytes in vitro. Int. J. Endocrinol. 2013, 2013. [CrossRef] [PubMed]
37. Sakat, S.S.; Mani, K.; Demidchenko, Y.O.; Gorbunov, E.A.; Tarasov, S.A.; Mathur, A.; Epstein, O.I. Release-active dilutions of diclofenac enhance anti-inflammatory effect of diclofenac in carrageenan-induced rat paw edema model. Inflammation 2014, 37, 1–9. [CrossRef] [PubMed]
38. Chu, X.; Agmo, A. Sexual incentive motivation in old male rats: The effects of sildenafil and a compound (impaza) stimulating endothelial no synthase. Pharmacol. Biochem. Behav. 2008, 89, 209–217. [CrossRef] [PubMed]
39. Chu, X.; Zhavbert, E.S.; Dugina, J.L.; Kheyfets, I.A.; Sergeeva, A.; Epstein, O.I.; Agmo, A. Effects of chronic treatment with the enos stimulator impaza on penis length and sexual behaviors in rats with a high baseline of sexual activity. Int. J. Impot. Res. 2014, 26, 35–40. [CrossRef] [PubMed]
40. Gavrilova, E.S.; Bobrovnik, S.A.; Sherriff, G.; Myslivets, A.A.; Tarasov, S.A.; Epstein, O.I. Novel approach to activity evaluation for release-active forms of anti-interferon-gamma antibodies based on enzyme-linked immunoassay. PLoS ONE 2014, 9. [CrossRef] [PubMed]
41. Pschenitza, M.; Gavrilova, E.S.; Tarasov, S.A.; Knopp, D.; Niessner, R.; Epstein, O.I. Application of a heterogeneous immunoassay for the quality control testing of release-active forms of diclofenac. Int. Immunopharmacol. 2014, 21, 225–230. [CrossRef] [PubMed]
42. Ghindilis, A.L.; Atanasov, P.; Wilkins, M.; Wilkins, E. Immunosensors: Electrochemical sensing and other engineering approaches. Biosens. Bioelectron. 1998, 13, 113–131. [CrossRef]
43. The European Parliament and the Council of the European Union. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 Amending Directive 2001/83/EC on the Community Code Relating to Medicinal Products for Human Use. OJ 2004, L136, 34–57. Available online: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2004_27/dir_2004_27_en.pdf (accessed on 18 December 2015).
44. European Pharmacopoeia, 7th ed.; Council of Europe: Strasbourg, France, 2011; Volume Supplement 7.2.
45. Validation of Analytical Procedures: Text and Methodology. Available online: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf (accessed on 18 December 2015).